SCHEMBL1409015

SCHEMBL1409015

C#CC(O)(c1ccc(N(C)C)cc1)c1ccc(N(C)C)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.59
ALDH1A1 P00352 11/20 0.46
TSHR P16473 6/20 0.46
ALOX15 P16050 4/20 0.46
HSD17B10 Q99714 4/20 0.46
MAPT P10636 4/20 0.39
HPGD P15428 1/20 0.39
MAPK1 P28482 4/20 0.38
CYP3A4 P08684 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
TP53 P04637 2/20 0.38
HBB P68871 1/20 0.38
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
APP P05067 1/20 0.35
ADRA2A P08913 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25954205 1.00 SLC2A1 (0.59) SLC2A1ALDH1A1TSHRALOX15HSD17B10
SCHEMBL4806571 0.93 SLC2A1 (0.52) SLC2A1ALDH1A1TSHRALOX15HSD17B10
SCHEMBL15763654 0.93 ALDH1A1 (0.54) SLC2A1ALDH1A1TSHRALOX15HSD17B10
SCHEMBL6491080 0.88 SLC2A1 (0.49) SLC2A1ALDH1A1TSHRHSD17B10MAPT
SCHEMBL11881317 0.83 SLC2A1 (0.64) SLC2A1ALDH1A1TSHRALOX15HSD17B10
SCHEMBL7124946 0.79 ALDH1A1 (0.44) ALDH1A1TSHRMAPTHPGDMAPK1
SCHEMBL17975204 0.77 SLC2A1 (0.52) SLC2A1ALDH1A1TSHRALOX15HSD17B10
SCHEMBL8782519 0.76 TSHR (0.44) ALDH1A1TSHRMAPTCYP3A4TDP1
Methylrosaniline SCHEMBL158959 0.75 SLC2A1 (1.00) SLC2A1ALDH1A1TSHRALOX15HSD17B10
SCHEMBL14384188 0.75 SLC2A1 (1.00) SLC2A1ALDH1A1TSHRALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2820027-B1 METATHESIS CATALYSTS CONTAINING ONIUM GROUPS APEIRON SYNTHESIS SA (PL) 2018-06-06 EP disclosed
US-9403860-B2 Metathesis catalysts containing onium groups APEIRON SYNTHESIS S.A. (PL) 2016-08-02 US disclosed
US-9403860-B2 Metathesis catalysts containing onium groups APEIRON SYNTHESIS S.A. (PL) 2016-08-02 US disclosed
US-9371345-B2 Metathesis catalysts containing onium groups APEIRON SYNTHESIS S.A. (PL) 2016-06-21 US disclosed
US-9371345-B2 Metathesis catalysts containing onium groups APEIRON SYNTHESIS S.A. (PL) 2016-06-21 US disclosed
US-20150274763-A1 Metathesis Catalysts Containing Onium Groups APEIRON SYNTHESIS S.A. (PL) 2015-10-01 US disclosed
US-20150274763-A1 Metathesis Catalysts Containing Onium Groups APEIRON SYNTHESIS S.A. (PL) 2015-10-01 US disclosed
US-8865029-B2 Photochromic polymer and composition comprising photochromic polymer Vivimed Labs Europe Ltd. (GB) 2014-10-21 US disclosed
US-8865029-B2 Photochromic polymer and composition comprising photochromic polymer Vivimed Labs Europe Ltd. (GB) 2014-10-21 US disclosed
US-8865029-B2 Photochromic polymer and composition comprising photochromic polymer Vivimed Labs Europe Ltd. (GB) 2014-10-21 US disclosed
US-20110147681-A1 Photochromic Polymer and Composition Comprising Photochromic Polymer ADVANCED POLYMERIK PTY LTD (AU) 2011-06-23 US disclosed
EP-2294114-A1 PHOTOCHROMIC POLYMER AND COMPOSITION COMPRISING PHOTOCHROMIC POLYMER Advanced Polymerik Pty Ltd (AU) 2011-03-16 EP disclosed
WO-2009146509-A1 PHOTOCHROMIC POLYMER AND COMPOSITION COMPRISING PHOTOCHROMIC POLYMER ADVANCED POLYMERIK PTY LTD (AU) 2009-12-10 WO disclosed
WO-2009146509-A1 PHOTOCHROMIC POLYMER AND COMPOSITION COMPRISING PHOTOCHROMIC POLYMER ADVANCED POLYMERIK PTY LTD (AU) 2009-12-10 WO disclosed
EP-1117656-B1 GREY COLOURING PHOTOCHROMIC FUSED PYRANS JAMES ROBINSON LTD (GB) 2002-05-29 EP disclosed
US-6387512-B1 FOR COLORING INKS, FUELS, PLASTICS OR GLASS JAMES ROBINSON LIMITED (GB) 2002-05-14 US disclosed
EP-1117656-A1 GREY COLOURING PHOTOCHROMIC FUSED PYRANS JAMES ROBINSON LIMITED (GB) 2001-07-25 EP disclosed
WO-2000018755-A1 GREY COLOURING PHOTOCHROMIC FUSED PYRANS JAMES ROBINSON LIMITED (GB) 2000-04-06 WO disclosed
WO-1999031081-A1 PH SENSITIVE PHOTOCHROMIC DYES JAMES ROBINSON LIMITED (GB) 1999-06-24 WO disclosed
US-3942988-A Photosensitive composition containing a polyhalogenated initiator and a cumulene dye former ADDRESSOGRAPH MULTIGRAPH CORPORATION (US) 1976-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150274763-A1 Metathesis Catalysts Containing Onium Groups MNS1, CYP2F1, MSMO1 SLC2A1 4455/4885ALDH1A1 901/4885TSHR 3956/4885
US-20110147681-A1 Photochromic Polymer and Composition Comprising Photochromic Polymer SMCHD1, PCNA, PARG SLC2A1 3074/4885ALDH1A1 4625/4885TSHR 4564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.